邻硝基芳酸衍生物抗肿瘤释药体系的可行性研究
[Abstract]:Small molecular compounds have long been studied as drug delivery systems. In this study, the metabolic design and drug delivery system of o-nitrophenoxyacetic acid compounds in tumor tissues were evaluated on the basis of previous experimental results. First of all, 16 compounds were synthesized, and the melting point, solubility, lipids water partition coefficient and acidity coefficient of phenoxyacetic acid compounds were determined, which supplemented the blank of the physical and chemical properties of these compounds. Then, the antimicrobial activity, free radical activity, anti-liver injury activity and vascular inhibition activity of o-nitrophenoxyacetic acid and its expected end product 2H-1- (4) benzo VA zizine-3 (4H) -one were studied. The results showed that o-nitro-phenoxyacetic acid and 2H-1- (4-benzo VA) -3 (4H) -one had inhibitory effects on both Staphylococcus aureus and Pseudomonas aeruginosa. The former tended to inhibit Pseudomonas aeruginosa and the latter tended to inhibit Staphylococcus aureus. Both o-nitro-phenoxyacetic acid and 2H-1- (4-benzoVA) -3 (4H) -ketone can inhibit hydroxyl radical, the latter is stronger than the former. O-nitrophenoxyacetic acid had no protective effect on carbon tetrachloride induced L02 injury and alcoholic L02 injury, but 2H-1C 4benzo VA zizine-3 (4H) -one had protective effect on both damage. Both o-nitro-phenoxyacetic acid and H-1- (4-benzo VA) -3 (4H) -ketone could control the growth of tumor blood vessels by inhibiting tumor cell secretion, but o-nitrophenoxyacetic acid could inhibit the growth signal of vascular cells. Inhibition of tumor angiogenesis may affect the growth of normal vascular cells, while Benzoxazine-3 (4H) -ketone does not affect the growth signal of vascular cells. The above results demonstrate the rationality of the design for the metabolism of o-nitrophenoxyacetic acid to 2H-1- (4H) -benzoxazine-3 (4H) -ketone in the tumor. Finally, the results of nitroreductase reduction of p-chloronitrobenzene proved that the nitro was first reduced to hydroxylamine intermediate product and then reduced to amino group in benzene ring. By detecting the nitroreductase products of o-nitrophenoxyacetic acid, the reduction process of o-nitrophenoxyacetic acid was investigated, and two release routes of 5-fluorouracil derivative of o-nitrophenoxyacetic acid were determined. In this paper, the effect of substituted phenoxyacetic acid ring on the reduction of p-nitrobenzene was studied through the reduction experiment of nitroreductase of o-nitrophenoxyacetic acid at different positions on benzene ring. The order of reduction from easy to difficult is: 4-fluoro-o-nitrophenoxyacetic acid (compound 1f), 5-fluoro-o-nitrophenoxyacetic acid (compound 1g), o-nitrophenoxyacetic acid (compound 1a), 4-methyl-o-nitrophenoxyacetic acid (compound 1c), 3-fluoro-o-nitrophenoxyacetic acid (compound 1e), 5-methyl-o-nitrophenoxyacetic acid (compound 1d), 3-methyl-o-nitrophenoxyacetic acid (compound 1b); In this paper, the effect of 伪 position substitution of ester bond on the hydrolysis of ester bond was studied by the experiment of enzymatic hydrolysis of ortho-nitrophenoxyacetic acid release model with different ester bond 伪 positions. The order of hydrolysis from difficult to easy is as follows: two methyl groups are introduced into the ester bond of drug model, one ethyl is introduced into the ester bond of drug model, and one methyl is introduced into the ester bond of drug model. By comparing 2- (4-fluoro-2-nitrophenoxy) -2-methylpropionic acid-5-fluorouracil (5-Fu) with 5-Fu, it was found that the former could not inhibit the proliferation of A549 cells. However, the cytotoxicity of A549 cells was significantly reduced, and the selectivity of inhibition on proliferation of A549 cells was much higher than that of 5-Fu.
【学位授予单位】:兰州大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R914;R96
【相似文献】
相关期刊论文 前3条
1 仝建波;王平;车挺;程芳玲;;苯并VA嗪酮衍生物类抗艾滋病药物3D-QSAR研究[J];原子与分子物理学报;2012年05期
2 夏坚;李江波;;苯并VA嗪酮衍生物对HIV-1逆转录酶抑制活性的QSAR研究极化连续介质模型(PCM)法的应用[J];高等学校化学学报;2012年08期
3 陈洪波,,谢伦嘉,罗宣德;左氧氟沙星中间体苯并VA嗪的拆分[J];中国医药工业杂志;1995年04期
相关会议论文 前10条
1 顾宜;冉起超;田巧;;含醛基苯并VA嗪的性能研究[A];复合材料——基础、创新、高效:第十四届全国复合材料学术会议论文集(上)[C];2006年
2 李觅;徐庆玉;李翔;王洛礼;;二甲苯型苯并VA嗪树脂的制备[A];第十二届中国覆铜板技术·市场研讨会论文集[C];2011年
3 梁佩茵;张朋立;徐日炜;吴一弦;余鼎声;;丁二胺型苯并VA嗪的合成、表征及性能研究[A];2011年全国高分子学术论文报告会论文摘要集[C];2011年
4 顾宜;;苯并VA嗪树脂的研究与应用进展[A];2010年全国高分子材料科学与工程研讨会学术论文集(上册)[C];2010年
5 胡永佳;刘麦女;丁涛;徐元清;房晓敏;;阻燃苯并VA嗪单体的合成及其表征[A];河南省化学会2010年学术年会论文摘要集[C];2010年
6 章婷婷;袁荞龙;黄发荣;;含炔丙基苯并VA嗪的合成及其热性能[A];2012年全国高分子材料科学与工程研讨会学术论文集(上册)[C];2012年
7 胡娇;彭康;李觅;耿芹;刘应玖;徐庆玉;王洛礼;;二胺型苯并VA嗪树脂的研究进展[A];第十四届中国覆铜板技术·市场研讨会论文集[C];2013年
8 杨坡;朱蓉琪;顾宜;;酚酞-苯胺型聚苯并VA嗪的氢键调控及其对热性能的影响[A];2013年全国高分子学术论文报告会论文摘要集——主题L:高性能树脂[C];2013年
9 陈建;黄坤;张妍s
本文编号:2354305
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2354305.html